Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from D.N. Church and colleagues provide new insights into breast cancer
July 31st, 2008
"Brain metastases (BM) are a significant complication of metastatic breast cancer (MBC). The high incidence of BM in HER2 overexpressing MBC is now well recognized, however, the optimal management of such patients is not yet clearly defined," researchers in Bristol, the United Kingdom report. "We aimed to analyze factors affecting survival after diagnosis of BM in patients treated in our center. Retrospective analysis of survival in all patients treated with antineoplastic therapy for BM from MBC in our institution between May 1st 2002 and April 30th 2005, according to HER2 expression and use of trastuzumab after diagnosis of BM. The median survival of the 26 patients...
Source: Women's Health Weekly (2008-07-31)
|
